This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study will test the hypothesis that integration of pharmacokinetic and viral drug resistance testing information maximizes the benefit of antiretroviral therapy in the management of treatment-experienced HIV-infected subjects.
Showing the most recent 10 out of 675 publications